Anaplastic thyroid carcinoma is one of the most aggressive and deadly cancers in humans and accounts for one to two cases per million persons annually. The rarity of this malignancy and the rapidity ...

Patients with anaplastic thyroid carcinoma can rarely be cured, but every effort should be made to prevent death due to suffocation. Between 1984 and 1999, 55 consecutive patients with anaplastic ...

Overall survival rates for adults diagnosed with anaplastic thyroid carcinoma are similar between those with a history of cancer and those with no previous cancer diagnosis, according to findings ...

Columbia University investigators report an increased risk of breast lymphomas after postmastectomy implant-based ...

Source Reference: Cabanillas ME, et al "Anti-programmed death ligand 1 plus targeted therapy in anaplastic thyroid carcinoma: A nonrandomized clinical trial" JAMA Oncol 2024; DOI: 10.1001 ...

Report Highlights Pharmaceutical and Healthcare latest pipeline guide Anaplastic Oligoastrocytoma - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development ...

The first-generation anaplastic lymphoma kinase (ALK) inhibitor crizotinib is active in patients with ALK gene (ALK)-rearranged non–small-cell lung cancer (ALK-positive NSCLC), but most patients ...

DelveInsight’s, “Anaplastic Thyroid Cancer Pipeline Insight 2025,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Anaplastic Thyroid Cancer pipeline ...

Archive Gonadotropin-Producing Anaplastic Large-Cell Carcinomas of the Lung Authors: Frank D. Fusco, M.D., and Saul W. Rosen, Ph.D., M.D. Author Info & Affiliations Published September 8, 1966 ...